HealthEquity raises fiscal year 2025 EPS and revenue outlook; analysts maintain mixed views and a "Moderate Buy" consensus at $103.83.
HealthEquity, Inc. (NASDAQ: HQY) has updated its fiscal year 2025 outlook, projecting EPS of 2.98-3.14 and revenue of $1.165-1.185 billion. Recently, it reported Q2 earnings of $0.55 EPS, exceeding estimates. Analysts have mixed views, with price targets ranging from $92 to $110, and a consensus rating of "Moderate Buy" at $103.83. Notably, Vice Chairman Stephen Neeleman sold 35,000 shares recently. The company has a market cap of $6.92 billion.
September 06, 2024
13 Articles